NEW YORK – Bluebird Bio on Friday said it will be purchased by funds managed by investment firms Carlyle and SK Capital Partners, after which it will become a privately held company. Under the terms ...

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

In a previous trial, patients with RSK2-high cancers had a significantly greater benefit from treatment with PMD-026 than those with RSK2-low cancers.

Blincyto plus chemo was approved for adult patients with Ph-negative, CD19-positive, and MRD-negative B-cell precursor acute lymphoblastic leukemia.

The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

NEW YORK – Cel-Sci on Thursday said it will initiate a Phase III registrational trial of its immunotherapy Multikine (leukocyte interleukin injection) in newly diagnosed, locally advanced head and ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.